Screening Outcomes and Long-term Data

Slides:



Advertisements
Similar presentations
Lab/ECG/Xray Rounds The EM Resident Provisionally Known as Sean Caine CCFP-EM March 5, 2008.
Advertisements

Cardiac Issues in Athletic Participation: To Screen or Not to Screen?
Syncope –cardiac causes James Gnanapragasam Paediatric cardiologist Southampton University Hospital Oxford University Hospital.
April 1 st, 2013 Heart Failure Education Series David N. Edwards, M.D. Ph.D. F.A.C.C. Advanced Heart Care, PA The Heart Hospital Baylor Plano.
ACE Personal Trainer Manual, 4th edition Chapter 16:
The Wellness Division of This program is designed to help our members identify their health risks and take steps to improve their health.
©2014 MFMER | slide-1 Cardiac Screening in Athletes A Brief Review Sara Filmalter, MD Mayo Clinic Florida Jacksonville Sports Medicine Symposium April.
Cardiac Pathology in Athletes. Sudden Death About 25 young patients die each year nationally in sudden-initially unexplained deaths on the field in all.
Sudden Cardiac Death and Sport
OBJ: IDENTIFY THE PROCESS INVOLVED WITH RECOGNIZING CARDIAC EMERGENCIES Sudden Cardiac Arrest.
Sudden Cardiac Arrest in Intercollegiate Athletics Are you prepared?
Sudden Cardiac Death in Young Athletes Yann Ping Pan, MD Ruey-Kang Chang, MD, MPH.
DOMENICO CORRADO, MD, PhD University of Padova, Italy
Early Detection of Hypertrophic Cardiomyopathy
1. Etiology of Hypertrophic Cardiomyopathy is mostly due to: A. Long-term Hypertension B. Aortic Stenosis C. Myocardial Ischemia D. Familial and Genetic.
CONGESTIVE HEART FAILURE By: Sade Jordan Donisha Grier.
Health Education on Heart Diseases Oromo community,Washington,DC May 9,2015 Teshome Geleta Deksissa, M.D.
The Cardiac Evaluation of the Athlete Daniel J. O’Rourke, MD, MS Veterans Affairs Medical Center Dartmouth-Hitchcock Medical Center.
Heart Conditions. Acute Chest pain Crushing pain Cardiac pain patterns Pain referred to left jaw, shoulder, arm Syncope Excessive sweating Pale skin Difficulty.
CARDIOVASCULAR DISEASES Heart Attack Definition- is the death of part of the heart muscle caused by lack of blood flow to the heart. A heart attack can.
Copyright © 2011 Delmar, Cengage Learning. ALL RIGHTS RESERVED. Chapter 26 Vital Signs.
LESSON 12 – INTRODUCTION TO BLOOD PRESSURE AND CIRCULATORY SYSTEM.
PREVENTION: PRE-PARTICIPATION PHYSICAL EXAMS Annise Nalepa, ATC, LAT Tarleton State University.
 This disease Narrows the blood vessels that carry oxygen-rich blood to your heart. This happens because of plaque build up in the vessels.  The coronary.
Allison Eliscu, MD, FAAP Rev. Aug Goals of Preparticipation Physical Identify abnormalities which could lead to sudden death Detect musculoskeletal.
Coarctation of the Aorta Sherly Fleurimont BSC-2086.
20 years of preventing young sudden cardiac deaths through awareness, screening and research and supporting affected families Alison Cox MBE Founder and.
The Heart 6 th Class Scoil Íde. What is your heart for ? Your heart is a muscle that pumps blood around the body via blood vessels. The heart is inside.
Genetics & Heart Disease Donald Ferrari, DO,FACC Main Line Healthcare Cardiology in Lionville Candace S. Peterson, MS, CGC Certified Genetic Counselor.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
PACES Survey ECG Screening November 2008 AHA Stuart Berger Robert Campbell Jonathan Drezner.
Every year, more than coronary bypass operations are performed in the USA., an industry worth $100 billion. The American bypass surgery industry.
“I Need This Form Filled Out”: Pediatric Sports Physical Assessment Aaron T Dorfman, MD Pediatric Cardiology New Jersey Section The Children’s Hospital.
Center for Coronary Artery THI
Victoria L. Vetter, MD, MPH, Youth Heart Watch Medical Director
Project ADAM®: Public Access Defibrillation (PAD) Programs in Schools
preventing young sudden cardiac deaths through
CSRC Think Tank 2017 FDA February 2017.
Heart Attack By: Taylor.
DR. PUNEET GARG B.H.M.S., M.D.(Paed.)
Sudden Cardiac Death in Young Athletes
Athletes and Sudden Cardiac Death
Helping you prevent heart disease, stroke, diabetes and kidney disease
Insert any picture or image you like here
Getting Started: Heart Safe School Accreditation.
Atrial Fibrillation: When Should You Consider Ablation?
All-cause mortality by treatment group
Common arrhythmia.
CASE HISTORY ISCHEMIC HEART DISEASE
ECHO SCREENING CLINICAL SESSION
Fig. 2.Baseline and the event polygraphic records show the 3 limb leads ECG and the pulse pressure at the right common femoral artery sheath. A: baseline.
Patient Medical Records
Cardiac Screening in Athletes A Brief Review
Injury Prevention Jenna Bidoglio, ATC Belleville High School
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
AED Training District Wide.
Hypertrophic Cardiomyopathy
Blood Pressure August 2015 Blood Pressure.
Radt 2992 Patient Care Exam 4 review, chapter 8.
Dirty Laundry.
Syncope in children.
Levine RA, DO. Miladinovic B, PhD. Nardell K, MD. Galas J, MD
Family Health History Health project.
Sudden Cardiac Arrest in Intercollegiate Athletics
Sudden Cardiac Arrest in Intercollegiate Athletics
Model Enhanced Classification of Serious Adverse Events
Volume 350, Issue 9087, (November 1997)
Heart Rate.
Family Health History Health project.
Presentation transcript:

Screening Outcomes and Long-term Data VICTORIA l Vetter, M.D.,MPH

Using Data to Determine Outcomes Screening using ECGs is occurring. Over 430,566 children screened by PHW members in past 10 years. Can we do it better and if so, how do we standardize and improve what is being done currently? What can we learn from these data? Can current screening help determine normal ECG findings? Does screening find cardiac conditions? If Yes, what happens to those children? If No, what happens? Can screening identify safety signals? Can screening prevent sudden cardiac death? If Yes, what type of screening is best?

Screening Results DATA, DATA, DATA Personal History Family History ECG ECHO Physical Exam Other Testing 

Post-Screening Data Outcomes DATA SHARING Post-Screening Data Outcomes ECHO ECG H&P FAMILY PCP Foundations Pharma Industry FDA Academia

Testing Data: Initial Encounter Physical Exam Demographic Data History Murmur Blood Pressure Marfan Stigmata Brachial vs. Femoral pulses Height and Weight Personal History Chest Pain/Shortness of Breath Syncope Exercise Intolerance Activity Family History Sudden death, syncope, seizure Specific SCD associated condition ECG ECHO

Testing Data Outcomes ECG ECHO Normal values Modifying factors Age Sex Race Ethnicity Modifying factors Activity Body habitus/BSA/BMI Blood Pressure Normal values Age Sex Race Ethnicity Modifying factors Activity Body habitus/BSA/BMI Blood Pressure

Testing Data Abnormalities ECG ECHO Diagnosis: WPW Possible Diagnosis: LQTS Abnormal Finding: LVH Normal True negative False negative (CPVT, Coronary artery anomaly) Diagnosis: HCM, Anomalous Coronary Artery Origin Possible Diagnosis: HCM vs. Athletic Heart Normal True negative False negative (HCM, ARVD, LVNC) Long-term Data and Outcomes

Testing Data Abnormalities Long-term Data and Outcomes Follow Up Testing: Type and Results Follow Up Diagnoses Validate “Definitive” Diagnosis and determine Outcomes WPW or LQTS Clarify Diagnosis LVH: HCM or Athletic Heart or False positive? Follow Those with No Diagnosis Do well long term Have Cardiac Event Core Annual Data

Testing Data Abnormalities Long-term Data and Outcomes Core Longitudinal Data: Annual Questions Is the child alive? Is the child well or not? Has the child died? Did the child have any heart test in the past year? Does the child have a new heart condition? Was the child started on any heart medication? Did the child have a heart procedure? Did the child have a hospital stay in the past year? Has the child had seizures or passed out with exercise?

Core Longitudinal Data How To Obtain How to Store and Access Family Assisted Automation Social Media Clearinghouse Data Warehouse/Repository Data Transmission

NEXT STEPS: Long-term Results and Outcomes Determine where can data be stored and how can it be accessed. Need Manual of Operations (MOO) on how to code the variables. Need Policies and Procedures on cleaning, storage, and access to data. Need Process to obtain follow up/outcome data after initial screens. Discuss different needs of academia, the FDA, Industry/PhRMA and Foundation/Grass Roots Groups. Determine other outcomes that should be added. What other questions does the group have?

Thank You!

Screening Process Variation Who, What, Where? Screening Organization Screening Location Data Acquisition Individuals Screened Equipment and Personnel Test Interpretation: Criteria and Personnel

Screening Process Variation What is Done? History Personal History Family History ECG ECHO Physical Exam Genetics

STANDARDIZATION: FITTING THE PIECES TOGETHER